Quantum-Si incorporated (QSI) is a Biotechnology company in the Healthcare sector, currently trading at $1.05. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
Analyst consensus target is QSI = $1 (-4.8% upside).
Valuation: QSI trades at a trailing Price-to-Earnings (P/E) of -1.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.12.
Financials: revenue is $2M, +81.1%/yr average growth. Net income is $101M (loss), growing at +8.8%/yr. Net profit margin is -4160.1% (negative). Gross margin is -135.5% (-180.6 pp trend).
Balance sheet: total debt is $4M against $220M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 7.64 (strong liquidity). Debt-to-assets is 1.7%. Total assets: $246M.
Analyst outlook: 1 / 2 analysts rate QSI as buy (50%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 73/100 (Pass), Growth 83/100 (Pass), Past 0/100 (Fail), Health 100/100 (Pass), Moat 0/100 (Fail), Future 38/100 (Fail), Income 10/100 (Fail).
